0
     

Report Added
Report already added
PEGylated Proteins Market in India - Manufacturing and Consumption, Outlook and Forecast 2020-2026

PEGylated Proteins Market in India - Manufacturing and Consumption, Outlook and Forecast 2020-2026

PEGylating has been widely used as a post-production modification methodology for improving biomedical efficacy and physicochemical properties of therapeutic proteins since the first PEGylated product was approved by Food and Drug Administration in the early 1990s._x000D_
_x000D_
This report contains market size and forecasts of PEGylated Proteins in India, including the following market information:_x000D_
India PEGylated Proteins Market Revenue, 2015-2020, 2021-2026, ($ millions)_x000D_
India PEGylated Proteins Market Consumption, 2015-2020, 2021-2026, (g)_x000D_
India PEGylated Proteins Production Capacity, 2015-2020, 2021-2026, (g)_x000D_
Top Five Competitors in India PEGylated Proteins Market 2019 (%)_x000D_
The global PEGylated Proteins market was valued at 3588.8 million in 2019 and is projected to reach US$ 4140 million by 2026, at a CAGR of 3.6% during the forecast period. While the PEGylated Proteins market size in India was US$ XX million in 2019, and it is expected to reach US$ XX million by the end of 2026, with a CAGR of XX% during 2020-2026._x000D_
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the PEGylated Proteins manufacturers, suppliers, distributors and industry experts on the impacts of the COVID-19 pandemic on businesses, with top challenges including ingredients and raw material delays, component and packaging shortages, reduced/cancelled orders from clients and consumers, and closures of production lines in some impacted areas._x000D_
This report also analyses and evaluates the COVID-19 impact on PEGylated Proteins production and consumption in India_x000D_
Total Market by Segment:_x000D_
India PEGylated Proteins Market, By Type, 2015-2020, 2021-2026 ($ millions) & (g)_x000D_
India PEGylated Proteins Market Segment Percentages, By Type, 2019 (%)_x000D_
Colony Stimulating Factors_x000D_
Interferons_x000D_
Erythropoietin (EPO)_x000D_
Recombinant Factor Viii_x000D_
Monoclonal Antibodies_x000D_
Others_x000D_
_x000D_
India PEGylated Proteins Market, By Application, 2015-2020, 2021-2026 ($ millions) & (g)_x000D_
India PEGylated Proteins Market Segment Percentages, By Application, 2019 (%)_x000D_
Cancer Treatment_x000D_
Hepatitis_x000D_
Chronic Kidney Disease_x000D_
Leukemia_x000D_
SCID_x000D_
Rheumatoid Arthritis & Crohn's Disease_x000D_
Others_x000D_
_x000D_
Competitor Analysis_x000D_
The report also provides analysis of leading market participants including:_x000D_
Total PEGylated Proteins Market Competitors Revenues in India, by Players 2015-2020 (Estimated), ($ millions)_x000D_
Total PEGylated Proteins Market Competitors Revenues Share in India, by Players 2019 (%)_x000D_
Total India PEGylated Proteins Market Competitors Sales, by Players 2015-2020 (Estimated), (g)_x000D_
Total India PEGylated Proteins Market Competitors Sales Market Share by Players 2019 ($ millions)_x000D_
Further, the report presents profiles of competitors in the market, including the following:_x000D_
ENZON Pharmaceuticals_x000D_
Merck Sharp & Dohme_x000D_
Roche_x000D_
Pfizer_x000D_
Amgen_x000D_
UCB_x000D_
1 Introduction to Research & Analysis Reports_x000D_
1.1 PEGylated Proteins Market Definition_x000D_
1.2 Market Segments_x000D_
1.2.1 Segment by Type_x000D_
1.2.2 Segment by Application_x000D_
1.3 India PEGylated Proteins Market Overview_x000D_
1.4 Features & Benefits of This Report_x000D_
1.5 Methodology & Sources of Information_x000D_
1.5.1 Research Methodology_x000D_
1.5.2 Research Process_x000D_
1.5.3 Base Year_x000D_
1.5.4 Report Assumptions & Caveats_x000D_
_x000D_
2 COVID-19 Impact: India PEGylated Proteins Overall Market Size_x000D_
2.1 India PEGylated Proteins Market Size: 2020 VS 2026_x000D_
2.2 India PEGylated Proteins Revenue, Prospects & Forecasts: 2015-2026_x000D_
2.3 India PEGylated Proteins Sales (Consumption): 2015-2026_x000D_
_x000D_
3 Company Landscape_x000D_
3.1 Top PEGylated Proteins Players in India (including Foreign and Local Companies)_x000D_
3.2 Top India PEGylated Proteins Companies Ranked by Revenue_x000D_
3.3 India PEGylated Proteins Revenue by Companies (including Foreign and Local Companies)_x000D_
3.4 India PEGylated Proteins Sales by Companies (including Foreign and Local Companies)_x000D_
3.5 India PEGylated Proteins Price by Manufacturer (2015-2020)_x000D_
3.6 Top 3 and Top 5 PEGylated Proteins Companies in India, by Revenue in 2019_x000D_
3.7 India Manufacturers PEGylated Proteins Product Type_x000D_
3.8 Tier 1, Tier 2 and Tier 3 PEGylated Proteins Players in India_x000D_
3.8.1 List of India Tier 1 PEGylated Proteins Companies_x000D_
3.8.2 List of India Tier 2 and Tier 3 PEGylated Proteins Companies_x000D_
_x000D_
4 Sights by Product_x000D_
4.1 Overview_x000D_
4.1.1 By Type - India PEGylated Proteins Market Size Markets, 2020 & 2026_x000D_
4.1.2 Colony Stimulating Factors_x000D_
4.1.3 Interferons_x000D_
4.1.4 Erythropoietin (EPO)_x000D_
4.1.5 Recombinant Factor Viii_x000D_
4.1.6 Monoclonal Antibodies_x000D_
4.1.7 Others_x000D_
4.2 By Type - India PEGylated Proteins Revenue & Forecasts_x000D_
4.2.1 By Type - India PEGylated Proteins Revenue, 2015-2020_x000D_
4.2.2 By Type - India PEGylated Proteins Revenue, 2021-2026_x000D_
4.2.3 By Type - India PEGylated Proteins Revenue Market Share, 2015-2026_x000D_
4.3 By Type - India PEGylated Proteins Sales & Forecasts_x000D_
4.3.1 By Type - India PEGylated Proteins Sales, 2015-2020_x000D_
4.3.2 By Type - India PEGylated Proteins Sales, 2021-2026_x000D_
4.3.3 By Type - India PEGylated Proteins Sales Market Share, 2015-2026_x000D_
4.4 By Type - India PEGylated Proteins Price (Manufacturers Selling Prices), 2015-2026_x000D_
5 Sights by Application_x000D_
5.1 Overview_x000D_
5.1.1 By Application - India PEGylated Proteins Market Size, 2020 & 2026_x000D_
5.1.2 Cancer Treatment_x000D_
5.1.3 Hepatitis_x000D_
5.1.4 Chronic Kidney Disease_x000D_
5.1.5 Leukemia_x000D_
5.1.6 SCID_x000D_
5.1.7 Rheumatoid Arthritis & Crohn's Disease_x000D_
5.1.8 Others_x000D_
5.2 By Application - India PEGylated Proteins Revenue & Forecasts_x000D_
5.2.1 By Application - India PEGylated Proteins Revenue, 2015-2020_x000D_
5.2.2 By Application - India PEGylated Proteins Revenue, 2021-2026_x000D_
5.2.3 By Application - India PEGylated Proteins Revenue Market Share, 2015-2026_x000D_
5.3 By Application - India PEGylated Proteins Sales & Forecasts_x000D_
5.3.1 By Application - India PEGylated Proteins Sales, 2015-2020_x000D_
5.3.2 By Application - India PEGylated Proteins Sales, 2021-2026_x000D_
5.3.3 By Application - India PEGylated Proteins Sales Market Share, 2015-2026_x000D_
5.4 By Application - India PEGylated Proteins Price (Manufacturers Selling Prices), 2015-2026_x000D_
6 Manufacturers & Brands Profiles_x000D_
6.1 ENZON Pharmaceuticals_x000D_
6.1.1 ENZON Pharmaceuticals Corporate Summary_x000D_
6.1.2 ENZON Pharmaceuticals Business Overview_x000D_
6.1.3 ENZON Pharmaceuticals PEGylated Proteins Major Product Offerings_x000D_
6.1.4 ENZON Pharmaceuticals Sales and Revenue in India (2015-2020)_x000D_
6.1.5 ENZON Pharmaceuticals Key News_x000D_
6.2 Merck Sharp & Dohme_x000D_
6.2.1 Merck Sharp & Dohme Corporate Summary_x000D_
6.2.2 Merck Sharp & Dohme Business Overview_x000D_
6.2.3 Merck Sharp & Dohme PEGylated Proteins Major Product Offerings_x000D_
6.2.4 Merck Sharp & Dohme Sales and Revenue in India (2015-2020)_x000D_
6.2.5 Merck Sharp & Dohme Key News_x000D_
6.3 Roche_x000D_
6.3.1 Roche Corporate Summary_x000D_
6.3.2 Roche Business Overview_x000D_
6.3.3 Roche PEGylated Proteins Major Product Offerings_x000D_
6.3.4 Roche Sales and Revenue in India (2015-2020)_x000D_
6.3.5 Roche Key News_x000D_
6.4 Pfizer_x000D_
6.4.1 Pfizer Corporate Summary_x000D_
6.4.2 Pfizer Business Overview_x000D_
6.4.3 Pfizer PEGylated Proteins Major Product Offerings_x000D_
6.4.4 Pfizer Sales and Revenue in India (2015-2020)_x000D_
6.4.5 Pfizer Key News_x000D_
6.5 Amgen_x000D_
6.5.1 Amgen Corporate Summary_x000D_
6.5.2 Amgen Business Overview_x000D_
6.5.3 Amgen PEGylated Proteins Major Product Offerings_x000D_
6.5.4 Amgen Sales and Revenue in India (2015-2020)_x000D_
6.5.5 Amgen Key News_x000D_
6.6 UCB_x000D_
6.6.1 UCB Corporate Summary_x000D_
6.6.2 UCB Business Overview_x000D_
6.6.3 UCB PEGylated Proteins Major Product Offerings_x000D_
6.6.4 UCB Sales and Revenue in India (2015-2020)_x000D_
6.6.5 UCB Key News_x000D_
6.7 Crealta (Savient)_x000D_
6.6.1 Crealta (Savient) Corporate Summary_x000D_
6.6.2 Crealta (Savient) Business Overview_x000D_
6.6.3 Crealta (Savient) PEGylated Proteins Major Product Offerings_x000D_
6.4.4 Crealta (Savient) Sales and Revenue in India (2015-2020)_x000D_
6.7.5 Crealta (Savient) Key News_x000D_
_x000D_
7 PEGylated Proteins Production Capacity, Export and Import Analysis_x000D_
7.1 PEGylated Proteins Production Capacity and Value in India, Situation Analysis and Prediction, 2015-2026_x000D_
7.1.1 India PEGylated Proteins Production Capacity, 2015-2026_x000D_
7.1.2 India PEGylated Proteins Production 2015-2026_x000D_
7.1.3 India PEGylated Proteins Production Value 2015-2026_x000D_
7.2 Key Local PEGylated Proteins Manufacturers in India_x000D_
7.2.1 India Key Local PEGylated Proteins Manufacturers Production Capacity_x000D_
7.2.2 India Key Local PEGylated Proteins Manufacturers Production_x000D_
7.2.3 India Key Local PEGylated Proteins Manufacturers Production Value_x000D_
7.2.4 The Proportion of PEGylated Proteins Production Sold in India and Sold Other Than India by Manufacturers_x000D_
7.3 PEGylated Proteins Export and Import in India_x000D_
7.3.1 India PEGylated Proteins Export Market_x000D_
7.3.2 India PEGylated Proteins Source of Imports_x000D_
_x000D_
8 COVID-19 Impact: Key Market Trends, Opportunity, Drivers and Restraints_x000D_
8.1 PESTLE Analysis for India PEGylated Proteins Market_x000D_
8.2 Market Opportunities & Trends_x000D_
8.3 Market Drivers_x000D_
8.4 Market Restraints_x000D_
_x000D_
9 COVID-19 Impact on PEGylated Proteins Supply Chain Analysis_x000D_
9.1 Supply Chain Analysis_x000D_
9.2 Upstream Market Analysis_x000D_
9.3 Downstream and Clients Market Analysis_x000D_
9.4 Marketing Channels Analysis_x000D_
9.4.1 Marketing Channels_x000D_
9.4.2 PEGylated Proteins Distributors and Sales Agents in India_x000D_
_x000D_
10 Conclusion_x000D_
_x000D_
11 Appendix_x000D_
11.1 Note_x000D_
11.2 Examples of Clients_x000D_
11.3 Disclaimer_x000D_
List of Tables_x000D_
Table 1. Key Players of PEGylated Proteins in India_x000D_
Table 2. Top Players in India, Ranking by Revenue (2019)_x000D_
Table 3. India PEGylated Proteins Revenue by Companies, (US$, Mn), 2015-2020_x000D_
Table 4. India PEGylated Proteins Revenue Share by Companies, 2015-2020_x000D_
Table 5. India PEGylated Proteins Sales by Companies, (g), 2015-2020_x000D_
Table 6. India PEGylated Proteins Sales Share by Companies, 2015-2020_x000D_
Table 7. Key Manufacturers PEGylated Proteins Price (2015-2020) (USD/mg)_x000D_
Table 8. India Manufacturers PEGylated Proteins Product Type_x000D_
Table 9. List of India Tier 1 PEGylated Proteins Companies, Revenue (US$, Mn) in 2019 and Market Share_x000D_
Table 10. List of India Tier 2 and Tier 3 PEGylated Proteins Companies, Revenue (US$, Mn) in 2019 and Market Share_x000D_
Table 11. By Type - PEGylated Proteins Revenue in India (US$, Mn), 2015-2020_x000D_
Table 12. By Type - PEGylated Proteins Revenue in India (US$, Mn), 2021-2026_x000D_
Table 13. By Type - PEGylated Proteins Sales in India (g), 2015-2020_x000D_
Table 14. By Type - PEGylated Proteins Sales in India (g), 2021-2026_x000D_
Table 15. By Application - PEGylated Proteins Revenue in India, (US$, Mn), 2015-2020_x000D_
Table 16. By Application - PEGylated Proteins Revenue in India, (US$, Mn), 2021-2026_x000D_
Table 17. By Application - PEGylated Proteins Sales in India, (g), 2015-2020_x000D_
Table 18. By Application - PEGylated Proteins Sales in India, (g), 2021-2026_x000D_
Table 19. ENZON Pharmaceuticals Corporate Summary_x000D_
Table 20. ENZON Pharmaceuticals PEGylated Proteins Product Offerings_x000D_
Table 21. ENZON Pharmaceuticals PEGylated Proteins Sales (g), Revenue (US$, Mn) and Average Price (USD/mg) (2015-2020)_x000D_
Table 22. Merck Sharp & Dohme Corporate Summary_x000D_
Table 23. Merck Sharp & Dohme PEGylated Proteins Product Offerings_x000D_
Table 24. Merck Sharp & Dohme PEGylated Proteins Sales (g), Revenue (US$, Mn) and Average Price (USD/mg) (2015-2020)_x000D_
Table 25. Roche Corporate Summary_x000D_
Table 26. Roche PEGylated Proteins Product Offerings_x000D_
Table 27. Roche PEGylated Proteins Sales (g), Revenue (US$, Mn) and Average Price (USD/mg) (2015-2020)_x000D_
Table 28. Pfizer Corporate Summary_x000D_
Table 29. Pfizer PEGylated Proteins Product Offerings_x000D_
Table 30. Pfizer PEGylated Proteins Sales (g), Revenue (US$, Mn) and Average Price (USD/mg) (2015-2020)_x000D_
Table 31. Amgen Corporate Summary_x000D_
Table 32. Amgen PEGylated Proteins Product Offerings_x000D_
Table 33. Amgen PEGylated Proteins Sales (g), Revenue (US$, Mn) and Average Price (USD/mg) (2015-2020)_x000D_
Table 34. UCB Corporate Summary_x000D_
Table 35. UCB PEGylated Proteins Product Offerings_x000D_
Table 36. UCB PEGylated Proteins Sales (g), Revenue (US$, Mn) and Average Price (USD/mg) (2015-2020)_x000D_
Table 37. Crealta (Savient) Corporate Summary_x000D_
Table 38. Crealta (Savient) PEGylated Proteins Product Offerings_x000D_
Table 39. Crealta (Savient) PEGylated Proteins Sales (g), Revenue (US$, Mn) and Average Price (USD/mg) (2015-2020)_x000D_
Table 40. PEGylated Proteins Production Capacity (g) of Local Manufacturers in India, 2015-2020_x000D_
Table 41. PEGylated Proteins Production (g) of Local Manufacturers in India, 2015-2020_x000D_
Table 42. India PEGylated Proteins Production Market Share of Local Manufacturers, 2015-2020_x000D_
Table 43. PEGylated Proteins Production Value (US$, Mn) of Local Manufacturers in India, 2015-2020_x000D_
Table 44. India PEGylated Proteins Production Value Market Share of Local Manufacturers, 2015-2020_x000D_
Table 45. The Percentage of PEGylated Proteins Production Sold in India and Sold Other Than India by Manufacturers_x000D_
Table 46. The Percentage of PEGylated Proteins Production Sold in India and Sold Other Than India by Manufacturers_x000D_
Table 47. Dangeguojia PEGylated Proteins Sales (Consumption), Production, Export and Import, 2015-2020_x000D_
Table 48. Raw Materials and Suppliers_x000D_
Table 49. PEGylated Proteins Downstream Clients in India_x000D_
Table 50. PEGylated Proteins Distributors and Sales Agents in India_x000D_
List of Figures_x000D_
Figure 1. PEGylated Proteins Segment by Type_x000D_
Figure 2. PEGylated Proteins Segment by Application_x000D_
Figure 3. Dangeguojia PEGylated Proteins Market Overview: 2020_x000D_
Figure 4. Key Caveats_x000D_
Figure 5. PEGylated Proteins Market Size in India, (US$, Mn) & (g): 2020 VS 2026_x000D_
Figure 6. India PEGylated Proteins Revenue, 2015-2026 (US$, Mn)_x000D_
Figure 7. PEGylated Proteins Sales in India: 2015-2026 (g)_x000D_
Figure 8. The Top 3 and 5 Players Market Share by PEGylated Proteins Revenue in 2019_x000D_
Figure 9. By Type - India PEGylated Proteins Incremental Growth, (US$, Mn), 2015-2026_x000D_
Figure 10. By Type - India PEGylated Proteins Market Share, 2015-2020_x000D_
Figure 11. By Type - India PEGylated Proteins Market Share, 2020-2026_x000D_
Figure 12. By Type - India PEGylated Proteins Price (USD/mg), 2015-2026_x000D_
Figure 13. By Application - PEGylated Proteins Revenue in India (US$, Mn), 2020 & 2026_x000D_
Figure 14. By Application - India PEGylated Proteins Market Share, 2015-2020_x000D_
Figure 15. By Application - India PEGylated Proteins Market Share, 2020-2026_x000D_
Figure 16. By Application -India PEGylated Proteins Price (USD/mg), 2015-2026_x000D_
Figure 17. India PEGylated Proteins Production Capacity (g), 2015-2026_x000D_
Figure 18. India PEGylated Proteins Actual Output (g), 2015-2026_x000D_
Figure 19. India PEGylated Proteins Production Value (US$, Mn), 2015-2026_x000D_
Figure 20. The Percentage of India PEGylated Proteins Export Destination, 2019_x000D_
Figure 21. The Source of Imports of India PEGylated Proteins, 2019_x000D_
Figure 22. PEST Analysis for India PEGylated Proteins Market in 2020_x000D_
Figure 23. PEGylated Proteins Market Opportunities & Trends in India_x000D_
Figure 24. PEGylated Proteins Market Drivers in India_x000D_
Figure 25. PEGylated Proteins Market Restraints in India_x000D_
Figure 26. PEGylated Proteins Industry Value Chain_x000D_

Kindly Fill The Form Below

Report Title: PEGylated Proteins Market in India - Manufacturing and Consumption, Outlook and Forecast 2020-2026


Valid Invalid number

SELECT A FORMAT

ADD TO CART BUY NOW